Boston Scientific Won’t Meet Guidance Due to Cyberattack
Boston Scientific is unlikely to meet its 2026 sales and profit forecasts after a cyberattack. The company stated the incident will materially impact results for the third quarter and the full year. While the firm reports it is on a road to recovery, the announcement caused its stock price to fall. The attack has disrupted the company's ability to hit previously established earnings guidance.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ Boston Scientific is unlikely to meet its 2026 sales and profit forecasts.
- ✓ A cyberattack will materially impact the company's third quarter and full-year results.
- ✓ The company's stock price fell following the announcement.
What changed
Boston Scientific confirmed a cyberattack will cause it to miss 2026 sales and profit forecasts.
Live updates
-
Boston Scientific Misses Guidance Following Cyberattack
Boston Scientific is unlikely to meet its 2026 sales and profit forecasts after a cyberattack. The company stated the incident will materially impact results for the third quarter and the full year. While the firm reports it is on a road to recovery, the announcement caused its stock price to fall. The attack has disrupted the company's ability to hit previously established earnings guidance.
Why it matters
Financial guidance serves as a benchmark for investor expectations regarding a company's growth and profitability. A material hit to quarterly and annual results suggests significant operational or financial disruption.
What is confirmed
- Boston Scientific is unlikely to meet its 2026 sales and profit forecasts.
- A cyberattack will materially impact the company's third quarter and full-year results.
- The company's stock price fell following the announcement.
What to watch next
- Disclosure of the specific nature or origin of the cyberattack
- Updated financial guidance figures for the remainder of 2026
confidence 100%Sources used for this update (7)
- wsj.com — Boston Scientific Won’t Meet Guidance Due to Cyberattack
- Reuters — Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
- finance.yahoo.com — Boston Scientific on road to recovery following cyberattack
- Seeking Alpha — Boston Scientific says cyberattack will materially hit Q3, full-year results (BSX:NYSE)
- Bloomberg.com — Boston Scientific Unlikely to Meet Forecasts After Cyber Attack
- Barron's — Boston Scientific ‘Unlikely to Meet’ Earnings Guidance After Cyberattack. Stock Falls.
- The Register — Boston Scientific left nursing its bottom line after cyberattack
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community